Achieve Life Sciences names Dr. Mark Rubinstein interim CMO
Go back to Achieve Life Sciences names Dr. Mark Rubinstein interim CMO| (NASDAQ: ACHV) | Delayed: 6.31 -0.19 (2.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.50 | 52 Week High | $ | |||
| Open | $6.47 | 52 Week Low | $ | |||
| Day High | $6.64 | P/E | N/A | |||
| Day Low | $6.28 | EPS | $ | |||
| Volume | 749,937 | |||||

